1 reply to this topic

[fishinghat]

Duloxetine recall: FDA expands recall to more than 233,000 bottles

 

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second most severe level as it could cause "temporary or medically reversible adverse health consequences."

 

 

[invalidusername]

That is an amazing find Hat. The initial link didn't work, but I have updated your post it so it now works to point to the second link.

 

This is really shocking news, although I cannot be completely surprised about such things happening, but it just shows you that the FDA need to keep further tabs on such pharma companies who have apparently shown themselves to be trustworthy in the areas of antidepressant medication. 

 

The post which you have stated has gone further across the web and I can only hope that it is recognised for what has been recognised.

 

As I said - a great find my friend.

 

I shall be passing this onto LDN who is still entrapped by the drug as I know he is subject to a number of issues as a result of immunity problems.